Role of telomere length in human carcinogenesis (Review)
- Authors:
- Aristidis Tsatsakis
- Tatiana Oikonomopoulou
- Taxiarchis Konstantinos Nikolouzakis
- Elena Vakonaki
- Manolis Tzatzarakis
- Matthaios Flamourakis
- Elisavet Renieri
- Persefoni Fragkiadaki
- Evaggelia Iliaki
- Maria Bachlitzanaki
- Vasiliki Karzi
- Ioanna Katsikantami
- Fotios Kakridonis
- Eleftheria Hatzidaki
- Maria Tolia
- Andrey A. Svistunov
- Demetrios A. Spandidos
- Dragana Nikitovic
- John Tsiaoussis
- Aikaterini Berdiaki
-
Affiliations: Laboratory of Toxicology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Creta InterClinic HHG, 71304 Heraklion, Greece, Laboratory of Microbiology, University Hospital of Heraklion, 71500 Heraklion, Greece, Department of Medical Oncology, Venizeleion General Hospital of Heraklion, 71409 Heraklion, Greece, Department of Spine Surgery and Scoliosis, KAT General Hospital, 14561 Athens, Greece, Department of Neonatology and Neonatal Intensive Care Unit (NICU), University Hospital of Heraklion, 71500 Heraklion, Greece, Department of Radiation Oncology, University Hospital of Crete, 71110 Heraklion, Greece, Department of Pharmacology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119146 Moscow, Russia, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Laboratory of Histology‑Embryology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Department of Anatomy, School of Medicine, University of Crete, 71003 Heraklion, Greece - Published online on: May 22, 2023 https://doi.org/10.3892/ijo.2023.5526
- Article Number: 78
-
Copyright: © Tsatsakis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Mattiuzzi C and Lippi G: Current cancer epidemiology. J Epidemiol Glob Health. 9:217–222. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tzanakakis G, Giatagana EM, Kuskov A, Berdiaki A, Tsatsakis A, Neagu M and Nikitovic D: Proteoglycans in the pathogenesis of hormone-dependent cancers: Mediators and effectors. Cancers (Basel). 12:24012020. View Article : Google Scholar : PubMed/NCBI | |
|
Maciejowski J and de Lange T: Telomeres in cancer: Tumor suppression and genome instability. Nat Rev Mol Cell Biol. 18:175–186. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shay JW and Wright WE: Telomeres and telomerase: Three decades of progress. Nat Rev Genet. 20:299–309. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lim CJ and Cech TR: Shaping human telomeres: From shelterin and CST complexes to telomeric chromatin organization. Nat Rev Mol Cell Biol. 22:283–298. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Dratwa M, Wysoczańska B, Łacina P, Kubik T and Bogunia-Kubik K: TERT-Regulation and roles in cancer formation. Front Immunol. 11:29302020. View Article : Google Scholar | |
|
Hrdličková R, Nehyba J and Bose HR: Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation. Mol Cell Biol. 32:4283–4296. 2012. View Article : Google Scholar | |
|
Sæbøe-Larssen S, Fossberg E and Gaudernack G: Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): Analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol. 7:262006. View Article : Google Scholar : PubMed/NCBI | |
|
Listerman I, Sun J, Gazzaniga F, Lukas JL and Blackburn EH: The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res. 73:2817–2828. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M and Inoue M: Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59:551–557. 1999.PubMed/NCBI | |
|
Tsoukalas D, Fragkiadaki P, Docea AO, Alegakis AK, Sarandi E, Vakonaki E, Salataj E, Kouvidi E, Nikitovic D, Kovatsi L, et al: Association of nutraceutical supplements with longer telomere length. Int J Mol Med. 44:218–226. 2019.PubMed/NCBI | |
|
Vasilopoulos E, Fragkiadaki P, Kalliora C, Fragou D, Docea AO, Vakonaki E, Tsoukalas D, Calina D, Buga AM, Georgiadis G, et al: The association of female and male infertility with telomere length (Review). Int J Mol Med. 44:375–389. 2019.PubMed/NCBI | |
|
Vakonaki E, Tsiminikaki K, Plaitis S, Fragkiadaki P, Tsoukalas D, Katsikantami I, Vaki G, Tzatzarakis MN, Spandidos DA and Tsatsakis AM: Common mental disorders and association with telomere length. Biomed Rep. 8:111–116. 2018.PubMed/NCBI | |
|
Razgonova MP, Zakharenko AM, Golokhvast KS, Thanasoula M, Sarandi E, Nikolouzakis K, Fragkiadaki P, Tsoukalas D, Spandidos DA and Tsatsakis A: Telomerase and telomeres in aging theory and chronographic aging theory (Review). Mol Med Rep. 22:1679–1694. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sfeir A and de Lange T: Removal of shelterin reveals the telomere end-protection problem. Science. 336:593–597. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Blasco MA: Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet. 6:611–622. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jäger K and Walter M: Therapeutic targeting of telomerase. Genes (Basel). 7:392016. View Article : Google Scholar : PubMed/NCBI | |
|
Tsatsakis A, Tsoukalas D, Fragkiadaki P, Vakonaki E, Tzatzarakis M, Sarandi E, Nikitovic D, Tsilimidos G and Alegakis AK: Developing BIOTEL: A Semi-Automated spreadsheet for estimating telomere length and biological age. Front Genet. 10:842019. View Article : Google Scholar : PubMed/NCBI | |
|
Dunham MA, Neumann AA, Fasching CL and Reddel RR: Telomere maintenance by recombination in human cells. Nat Genet. 26:447–450. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Teng SC and Zakian VA: Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol Cell Biol. 19:8083–8093. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Cesare A and Reddel R: Alternative lengthening of telomeres: Models mechanisms and implications. Nat Rev Genet. 11:319–330. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Henson J, Neumann AA, Yeager TR and Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene. 21:598–610. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, et al: Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol. 179:1608–1615. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Demanelis K, Jasmine F, Chen LS, Chernoff M, Tong L, Delgado D, Zhang C, Shinkle J, Sabarinathan M, Lin H, et al: Determinants of telomere length across human tissues. Science. 369:eaaz68762020. View Article : Google Scholar : PubMed/NCBI | |
|
Peleteiro B, Padrão P, Castro C, Ferro A, Morais S and Lunet N: Worldwide burden of gastric cancer in 2012 that could have been prevented by increasing fruit and vegetable intake and predictions for 2025. Br J Nutr. 115:851–859. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Doherty JA, Grieshober L, Houck JR, Barnett MJ, Tapsoba JD, Thornquist M, Wang CY, Goodman GE and Chen C: Telomere length and lung cancer mortality among heavy smokers. Cancer Epidemiol Biomarkers Prev. 27:829–837. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Leão R, Apolónio JD, Lee D, Figueiredo A, Tabori U and Castelo-Branco P: Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: Clinical impacts in cancer. J Biomed Sci. 251:222018. View Article : Google Scholar | |
|
Barthel FP, Wei W, Tang M, Martinez-Ledesma E, Hu X, Amin SB, Akdemir KC, Seth S, Song X, Wang Q, et al: Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat Genet. 49:349–357. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Albertson DG: Gene amplification in cancer. Trends Genet. 22:447–455. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
McClintock B: The fusion of broken ends of chromosomes following nuclear fusion. Proc Natl Acad Sci. 28:458–463. 1942. View Article : Google Scholar : PubMed/NCBI | |
|
Valentijn L, Koster J, Zwijnenburg D, Hasselt NE, van Sluis P, Volckmann R, van Noesel MM, George RE, Tytgat GA, Molenaar JJ and Versteeg R: NH-N and 2015 undefined: TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nat Genet. 47:1411–1414. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kyo S, Takakura M, Fujiwara T and Inoue M: Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Wiley Online Libr. 99:1528–1538. 2008. | |
|
Lewis KA and Tollefsbol TO: Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms. Front Genet. 7:832016. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng L, Montironi R and Lopez-Beltran A: TERT promoter mutations occur frequently in urothelial papilloma and papillary urothelial neoplasm of low malignant potential. Eur Urol. 71:497–498. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Deaton AM and Bird A: CpG islands and the regulation of transcription. Genes Dev. 25:1010–1022. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Lipman T, Zhukova N, Walker EJ, Martin D, Merino D, et al: Methylation of the TERT promoter and risk stratification of childhood brain tumours: An integrative genomic and molecular study. Lancet Oncol. 14:534–542. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Castelo-Branco P, Leão R, Lipman T, Campbell B, Lee D, Price A, Zhang C, Heidari A, Stephens D, Boerno S, et al: A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: A retrospective cohort study. Oncotarget. 7:57726–57736. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sepehri Z, Beacon TH, Osman FDS, Jahan S and Davie JR: DNA methylation and chromatin modifications. Nutritional Epigenomics. 13–36. 2019. View Article : Google Scholar | |
|
Bert SA, Robinson MD, Strbenac D, Statham AL, Song JZ, Hulf T, Sutherland RL, Coolen MW, Stirzaker C and Clark SJ: Regional Activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell. 23:9–22. 2013. View Article : Google Scholar | |
|
Hrdličková R, Nehyba J, Bargmann W and Bose HR: Multiple tumor suppressor microRNAs regulate telomerase and TCF7 an important transcriptional regulator of the Wnt pathway. PLoS One. 9:e869902014. View Article : Google Scholar | |
|
Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, et al: Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci. 99:280–286. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kachuri L, Helby J, Bojesen SE, Christiani DC, Su L, Wu X, Tardón A, Fernández-Tardón G, Field JK, Davies MP, et al: Investigation of leukocyte telomere length and genetic variants in chromosome 5p15.33 as prognostic markers in lung cancer. Cancer Epidemiol Biomarkers Prev. 28:1228–1237. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xue Y, Guo X, Huang X, Zhu Z, Chen M, Chu J, Yang G, Wang Q and Kong X: Shortened telomere length in peripheral blood leukocytes of patients with lung cancer, chronic obstructive pulmonary disease in a high indoor air pollution region in China. Mutat Res. 858-860:5032502020. View Article : Google Scholar | |
|
Steiner B, Ferrucci LM, Mirabello L, Lan Q, Hu W, Liao LM, Savage SA, De Vivo I, Hayes RB, Rajaraman P, et al: Association between coffee drinking and telomere length in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. PLoS One. 15:e02269722020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun B, Wang Y, Kota K, Shi Y, Motlak S, Makambi K, Loffredo CA, Shields PG, Yang Q, Harris CC and Zheng YL: Telomere length variation: A potential new telomere biomarker for lung cancer risk. Lung Cancer. 88:297–303. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, Kim CH, Kam S, Jung TH and Park JY: Telomere length and the risk of lung cancer. Cancer Sci. 99:385–1389. 2008. View Article : Google Scholar | |
|
Sanchez-Espiridion B, Chen M, Chang JY, Lu C, Chang DW, Roth JA, Wu X and Gu J: Telomere length in peripheral blood leukocytes and lung cancer risk: A large case-control study in Caucasians. Cancer Res. 74:2476–2486. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Jeon HS, Choi JE, Jung DK, Choi YY, Kang HG, Lee WK, Yoo SS, Lim JO and Park JY: Telomerase activity and the risk of lung cancer. J Korean Med Sci. 27:141–145. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dobija-Kubica K, Zalewska-Ziob M, Bruliński K, Rogoziński P, Wiczkowski A, Gawrychowska A and Gawrychowski J: Telomerase activity in non-small cell lung cancer. Kardiochir Torakochirurgia Pol. 13:15–20. 2016.PubMed/NCBI | |
|
Li J, Zhang L, Zhu H, Pan W, Zhang N, Li Y and Yang M: Leukocyte telomere length and clinical outcomes of advanced lung adenocarcinoma patients with epidermal growth factor receptor tyrosine kinase inhibitors treatment. DNA Cell Biol. 37:903–908. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Zhao Q, Zhu W, Liu T, Xie SH, Zhong LX, Cai YY, Li XN, Liang M, Chen W, et al: The association of telomere length in peripheral blood cells with cancer risk: A systematic review and meta-analysis of prospective studies. Cancer Epidemiol Biomarkers Prev. 26:1381–1390. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cao X, Huang M, Zhu M, Fang R, Ma Z, Jiang T, Dai J, Ma H, Jin G, Shen H, et al: Mendelian randomization study of telomere length and lung cancer risk in East Asian population. Cancer Med. 8:7469–7476. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Machiela MJ, Hsiung CA, Shu XO, Seow WJ, Wang Z, Matsuo K, Hong YC, Seow A, Wu C, Hosgood HD, et al: Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia. Int J Cancer. 137:311–319. 2015. View Article : Google Scholar | |
|
Yuan JM, Beckman KB, Wang R, Bull C, Adams-Haduch J, Huang JY, Jin A, Opresko P, Newman AB, Zheng YL, et al: Leukocyte telomere length in relation to risk of lung adenocarcinoma incidence: Findings from the Singapore Chinese Health Study. Int J Cancer. 142:2234–2243. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
de-Torres JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, Pío R, Pajares MJ, Campo A, Berto J, Montuenga L, Del Mar Ocon M, et al: Telomere length, COPD and emphysema as risk factors for lung cancer. Eur Respir J. 49:16015212017. View Article : Google Scholar : PubMed/NCBI | |
|
Telomeres Mendelian Randomization Collaboration; Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, et al: Association between telomere length and risk of cancer and non-neoplastic diseases: A mendelian randomization study. JAMA Oncol. 3:636–651. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Goh F, Yang IA, Bowman RV and Fong KM: Subtype variation and actionability of telomere length abnormality in lung cancer. Transl Lung Cancer Res. 7(Suppl 3): S251–S253. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kachuri L, Latifovic L, Liu G and Hung RJ: Systematic review of genetic variation in chromosome 5p15.33 and telomere length as predictive and prognostic biomarkers for lung cancer. Cancer Epidemiol Biomarkers Prev. 25:1537–1549. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Vaiciulis P, Liutkeviciene R, Liutkevicius V, Vilkeviciute A, Gedvilaite G and Uloza V: Association of relative leucocyte telomere length and gene single nucleotide polymorphisms (TERT, TRF1, TNKS2) in laryngeal squamous cell carcinoma. Cancer Genomics Proteomics. 17:431–439. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Han P, Dang Z, Shen Z, Dai H, Bai Y, Li B and Shao Y: Association of SNPs in the OBFC1 gene and laryngeal carcinoma in Chinese Han male population. Int J Clin Oncol. 24:1042–1048. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lei H, Feng D, Zhou F, Xu H, Tang T, Yu H, Xie C and Zhou Y: Expression of human protection of telomere 1 correlates with telomere length and radiosensitivity in the human laryngeal cancer Hep-2 cell line. Oncol Lett. 10:1149–1154. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Xiao BK, Liu JP, Chen SM and Tao ZZ: Alternative lengthening of telomeres in hTERT-inhibited laryngeal cancer cells. Cancer Sci. 101:1769–1776. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Broberg K, Björk J, Paulsson K, Höglund M and Albin M: Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 26:1263–1271. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Xu Y, Xu J, Chancoco H and Gu J: Leukocyte telomere length and bladder cancer risk: A large case-control study and mendelian randomization analysis. Cancer Epidemiol Biomarkers Prev. 30:203–209. 2021. View Article : Google Scholar | |
|
Pavanello S, Carta A, Mastrangelo G, Campisi M, Arici C and Porru S: Relationship between telomere length, genetic traits and Environmental/Occupational exposures in bladder cancer risk by structural equation modelling. Int J Environ Res Public Health. 15:52017. View Article : Google Scholar : PubMed/NCBI | |
|
McGrath M, Wong JY, Michaud D, Hunter DJ and De Vivo I: Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 16:815–819. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lin J, Blalock JA, Chen M, Ye Y, Gu J, Cohen L, Cinciripini PM and Wu X: Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiol Biomarkers Prev. 24:336–343. 2015. View Article : Google Scholar : | |
|
Yu C, Hequn C, Longfei L, Long W, Zhi C, Feng Z, Jinbo C, Chao L and Xiongbing Z: GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis. Oncotarget. 8:3246–3258. 2017. View Article : Google Scholar : | |
|
Hosen I, Rachakonda PS, Heidenreich B, de Verdier PJ, Ryk C, Steineck G, Hemminki K and Kumar R: Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. Int J Cancer. 137:1621–1629. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fernandez-Gomez J, Escaf Barmadah S, Gosalbez D, Rodriguez-Faba O, Jalon A, Gonzalez R, Garcia Miralles T and Calas A: Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique). Eur Urol. 48:432–437. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Wang Y, Kota KK, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Gouda I, et al: Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian. Carcinogenesis. 36:1284–1290. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gu J, Chen M, Shete S, Amos CI, Kamat A, Ye Y, Lin J, Dinney CP and Wu X: A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res (Phila). 4:514–521. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Holzmann K, Blin N, Welter C, Zang KD, Seitz G and Henn W: Telomeric associations and loss of telomeric DNA repeats in renal tumors. Genes Chromosomes Cancer. 6:178–181. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Mehle C, Ljungberg B and Roos G: Telomere shortening in renal cell carcinoma. Cancer Res. 54:236–241. 1994.PubMed/NCBI | |
|
Dahse R, Fiedler W, Junker K, Schlichter A, Schubert J and Claussen U: Telomerase activity and telomere lengths: Alterations in renal cell carcinomas. Kidney Int. 56:1289–1290. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Pal D, Sharma U, Khajuria R, Singh SK, Kakkar N and Prasad R: Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: Plausible predictive and diagnostic markers. Gene. 562:145–151. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, et al: Leukocyte telomere length and renal cell carcinoma survival in two studies. Br J Cancer. 117:752–755. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hofmann JN, Lan Q, Cawthon R, Hosgood HD III, Shuch B, Moore LE, Rothman N, Chow WH and Purdue MP: A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev. 22:997–1000. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hofmann JN, Baccarelli A, Schwartz K, Davis FG, Ruterbusch JJ, Hoxha M, McCarthy BJ, Savage SA, Wacholder S, Rothman N, et al: Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study. Br J Cancer. 105:1772–1775. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Svenson U, Ljungberg B and Roos G: Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res. 69:2896–2901. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Morais M, Dias F, Teixeira AL and Medeiros R: Telomere length in renal cell carcinoma: The Jekyll and Hyde biomarker of ageing of the kidney. Cancer Manag Res. 12:1669–1679. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, et al: Genetic variants related to longer telomere length are associated with increased risk of renal cell carcinoma. Eur Urol. 72:747–754. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
de Martino M, Taus C, Lucca I, Hofbauer SL, Haitel A, Shariat SF and Klatte T: Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology. Mol Carcinog. 55:1458–1466. 2016. View Article : Google Scholar | |
|
Svenson U, Grönlund E, Söderström I, Sitaram RT, Ljungberg B and Roos G: Telomere length in relation to immunological parameters in patients with renal cell carcinoma. PLoS One. 8:e555432013. View Article : Google Scholar : PubMed/NCBI | |
|
Endén K, Tainio J, Hou M, Suominen A, Pakarinen M, Huang T, Söder O, Jalanko H, Jahnukainen K and Jahnukainen T: Telomere length regulators are activated in young men after pediatric kidney transplantation compared to healthy controls and survivors of childhood cancer-A cross-sectional study. Pediatr Transplant. 23:e135502019. View Article : Google Scholar : PubMed/NCBI | |
|
HaydeéCottliar AS, Noriega MF, Narbaitz M, Rodríguez A and Slavutsky IR: Association between telomere length and BCL2 gene rearrangements in low- and high-grade non-Hodgkin lymphomas. Cancer Genet Cytogenet. 171:1–8. 2006. View Article : Google Scholar | |
|
Widmann TA, Herrmann M, Taha N, König J and Pfreundschuh M: Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol. 35:939–946. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lan Q, Cawthon R, Shen M, Weinstein SJ, Virtamo J, Lim U, Hosgood HD III, Albanes D and Rothman N: A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 15:7429–7433. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, et al: Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet. 25:1663–1676. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JJ, Nam CE, Cho SH, Park KS, Chung IJ and Kim HJ: Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol. 82:492–495. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Remes K, Norrback KF, Rosenquist R, Mehle C, Lindh J and Roos G: Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer. 82:601–607. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Adamson DJ, King DJ and Haites NE: Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet. 61:204–206. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S and Moore MA: Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia. 12:13–24. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Borssén M, Cullman I, Norén-Nyström U, Sundström C, Porwit A, Forestier E and Roos G: hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: Associations with immunophenotype and cytogenetic subgroup. Exp Hematol. 39:1144–1151. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Fang M, Sun X and Sun J: Telomerase activity and telomere length in acute leukemia: Correlations with disease progression, subtypes and overall survival. Int J Lab Hematol. 32:230–238. 2010. View Article : Google Scholar | |
|
Eskandari E, Hashemi M, Naderi M, Bahari G, Safdari V and Taheri M: Leukocyte telomere length shortening, hTERT genetic polymorphisms and risk of childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 19:1515–1521. 2018.PubMed/NCBI | |
|
Sheng X, Zhang L, Luo D, Tong N, Wang M, Fang Y, Li J and Zhang Z: A common variant near TERC and telomere length are associated with susceptibility to childhood acute lymphoblastic leukemia in Chinese. Leuk Lymphoma. 53:1688–1692. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Takauchi K, Tashiro S, Ohtaki M and Kamada N: Telomere reduction of specific chromosome translocation in acute myelocytic leukemia. Jpn J Cancer Res. 85:127–130. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Sieglová Z, Zilovcová S, Cermák J, Ríhová H, Brezinová D, Dvoráková R, Marková M, Maaloufová J, Sajdová J, Brezinová J, et al: Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: A marker of disease prognosis? Leuk Res. 28:1013–1021. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Lansdorp PM: Maintenance of telomere length in AML. Blood Adv. 1:2467–2472. 2017. View Article : Google Scholar | |
|
Wang Y, Wang T, Dagnall C, Haagenson M, Spellman SR, Hicks B, Jones K, Lee SJ, Savage SA and Gadalla SM: Relative telomere length before hematopoietic cell transplantation and outcome after unrelated donor hematopoietic cell transplantation for acute leukemia. Biol Blood Marrow Transplant. 23:1054–1058. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Swiggers SJ, Kuijpers MA, de Cort MJ, Beverloo HB and Zijlmans JM: Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes. Genes Chromosomes Cancer. 45:247–256. 2006. View Article : Google Scholar | |
|
Behrens YL, Thomay K, Hagedorn M, Ebersold J, Schmidt G, Lentes J, Davenport C, Schlegelberger B and Göhring G: Jumping translocations: Short telomeres or pathogenic TP53 variants as underlying mechanism in acute myeloid leukemia and myelodysplastic syndrome? Genes Chromosomes Cancer. 58:139–148. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Watts JM, Dumitriu B, Hilden P, Kishtagari A, Rapaport F, Chen C, Ahn J, Devlin SM, Stein EM, Rampal R, et al: Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia. Leuk Res. 49:62–65. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li AM, Hyagu S, Maze D, Schreiber R, Sirrs S, Stockler-Ipsiroglu S, Sutherland H, Vercauteren S and Schultz KR: Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length. Pediatr Hematol Oncol. 35:45–51. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Aalbers AM, Calado RT, Young NS, Zwaan CM, Wu C, Kajigaya S, Coenen EA, Baruchel A, Geleijns K, de Haas V, et al: Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia. Leukemia. 27:1786–1789. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Song DY, Kim JA, Jeong D, Yun J, Kim SM, Lim K, Park SN, Im K, Choi S, Yoon SS and Lee DS: Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population. PLoS One. 14:e02201772019. View Article : Google Scholar : PubMed/NCBI | |
|
Jebaraj BMC, Tausch E, Landau DA, Bahlo J, Robrecht S, Taylor-Weiner AN, Bloehdorn J, Scheffold A, Mertens D, Böttcher S, et al: Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia. Leukemia. 33:2183–2194. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Thomay K, Fedder C, Hofmann W, Kreipe H, Stadler M, Titgemeyer J, Zander I, Schlegelberger B and Göhring G: Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions. Ann Hematol. 96:1493–1500. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Steinbrecher D, Jebaraj BMC, Schneider C, Edelmann J, Cymbalista F, Leblond V, Delmer A, Ibach S, Tausch E, Scheffold A, et al: Telomere length in poor-risk chronic lymphocytic leukemia: Associations with disease characteristics and outcome. Leuk Lymphoma. 59:1614–1623. 2018. View Article : Google Scholar | |
|
Strefford JC, Kadalayil L, Forster J, Rose-Zerilli MJ, Parker A, Lin TT, Heppel N, Norris K, Gardiner A, Davies Z, et al: Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: Data from the UK LRF CLL4 trial. Leukemia. 29:2411–2414. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dos Santos P, Panero J, Palau Nagore V, Stanganelli C, Bezares RF and Slavutsky I: Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia. Tumour Biol. 36:8317–8324. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Palma M, Parker A, Hojjat-Farsangi M, Forster J, Kokhaei P, Hansson L, Osterborg A and Mellstedt H: Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia. Exp Hematol. 41:615–626. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sellmann L, de Beer D, Bartels M, Opalka B, Nückel H, Dührsen U, Dürig J, Seifert M, Siemer D, Küppers R, et al: Telomeres and prognosis in patients with chronic lymphocytic leukaemia. Int J Hematol. 93:74–82. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Roos G, Kröber A, Grabowski P, Kienle D, Bühler A, Döhner H, Rosenquist R and Stilgenbauer S: Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood. 111:2246–2252. 2008. View Article : Google Scholar | |
|
Lin TT, Letsolo BT, Jones RE, Rowson J, Pratt G, Hewamana S, Fegan C, Pepper C and Baird DM: Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: Evidence for a telomere crisis. Blood. 116:1899–1907. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ojha J, Codd V, Nelson CP, Samani NJ, Smirnov IV, Madsen NR, Hansen HM, de Smith AJ, Bracci PM, Wiencke JK, et al: ENGAGE Consortium Telomere Group. Genetic variation associated with longer telomere length increases risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 25:1043–1049. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wysoczanska B, Dratwa M, Gebura K, Mizgala J, Mazur G, Wrobel T and Bogunia-Kubik K: Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia. Onco Targets Ther. 12:4309–4320. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Furtado FM, Scheucher PS, Santana BA, Scatena NF, Calado RT, Rego EM, Matos DM and Falcão RP: Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A. Braz J Med Biol Res. 50:e60192017. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Kost SEF, Beiggi S, Zhang Y, Schmidt R, Nugent Z, Marshall A, Banerji V, Gibson SB and Johnston JB: Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia. Leuk Res. 86:1062202019. View Article : Google Scholar : PubMed/NCBI | |
|
Kaifie A, Schikowsky C, Vasko T, Kraus T, Brümmendorf TH and Ziegler P: Additional benefits of telomere length (TL) measurements in chronic lymphocytic leukemia. Leuk Lymphoma. 60:541–543. 2019. View Article : Google Scholar | |
|
Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Kawakubo K, Shay JW and Toyama K: The relationship between telomere length and therapy-associated cytogenetic responses in patients with chronic myeloid leukemia. Cancer. 79:1552–1560. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Brümmendorf TH, Holyoake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ, Eaves AC and Lansdorp PM: Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood. 95:1883–1890. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Bouillon AS, Ventura Ferreira MS, Awad SA, Richter J, Hochhaus A, Kunzmann V, Dengler J, Janssen J, Ossenkoppele G, Westerweel PE, et al: Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia. Blood Adv. 2:1572–1579. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S, Kusec R, Gaiger A, Littlewood TJ, Peniket AJ and Wainscoat JS: Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am J Hematol. 61:5–9. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Drummond M, Lennard A, Brûmmendorf T and Holyoake T: Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia. Leuk Lymphoma. 45:1775–1781. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Keller G, Brassat U, Braig M, Heim D, Wege H and Brümmendorf TH: Telomeres and telomerase in chronic myeloid leukaemia: Impact for pathogenesis, disease progression and targeted therapy. Hematol Oncol. 27:123–129. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Boultwood J, Peniket A, Watkins F, Shepherd P, McGale P, Richards S, Fidler C, Littlewood TJ and Wainscoat JS: Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase. Blood. 96:358–361. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Caocci G, Greco M, Delogu G, Secchi C, Martino B, Labate C, Abruzzese E, Trawinska MM, Galimberti S, Orru F, et al: Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients. J Hematol Oncol. 9:632016. View Article : Google Scholar : PubMed/NCBI | |
|
Samassekou O, Ntwari A, Hébert J and Yan J: Individual telomere lengths in chronic myeloid leukemia. Neoplasia. 11:1146–1154. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Nikolouzakis TK, Falzone L, Lasithiotakis K, Krüger-Krasagakis S, Kalogeraki A, Sifaki M, Spandidos DA, Chrysos E, Tsatsakis A and Tsiaoussis J: Current and future trends in molecular biomarkers for diagnostic, prognostic, and predictive purposes in non-melanoma skin cancer. J Clin Med. 9:28682020. View Article : Google Scholar : PubMed/NCBI | |
|
Llorca-Cardeñosa MJ, Peña-Chilet M, Mayor M, Gomez-Fernandez C, Casado B, Martin-Gonzalez M, Carretero G, Lluch A, Martinez-Cadenas C, Ibarrola-Villava M and Ribas G: Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk. Eur J Cancer. 50:3168–3177. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY and Rollison DE: Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol. 37:434–439. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bodelon C, Pfeiffer RM, Bollati V, Debbache J, Calista D, Ghiorzo P, Fargnoli MC, Bianchi-Scarra G, Peris K, Hoxha M, et al: On the interplay of telomeres, nevi and the risk of melanoma. PLoS One. 7:e524662012. View Article : Google Scholar | |
|
Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ and De Vivo I: A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 129:415–421. 2009. View Article : Google Scholar : | |
|
Nan H, Du M, De Vivo I, Manson JE, Liu S, McTiernan A, Curb JD, Lessin LS, Bonner MR, Guo Q, et al: Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 71:6758–6763. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Burke LS, Hyland PL, Pfeiffer RM, Prescott J, Wheeler W, Mirabello L, Savage SA, Burdette L, Yeager M, Chanock S, et al: Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One. 8:711212013. View Article : Google Scholar | |
|
Caini S, Raimondi S, Johansson H, De Giorgi V, Zanna I, Palli D and Gandini S: Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: A review of the literature and meta-analysis. J Dermatol Sci. 80:168–174. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Rachakonda S, Srinivas N, Mahmoudpour SH, Garcia-Casado Z, Requena C, Traves V, Soriano V, Cardelli M, Pjanova D, Molven A, et al: Telomere length and survival in primary cutaneous melanoma patients. Sci Rep. 8:109472018. View Article : Google Scholar : PubMed/NCBI | |
|
Viceconte N, Dheur MS, Majerova E, Pierreux CE, Baurain JF, van Baren N and Decottignies A: Highly aggressive metastatic melanoma cells unable to maintain telomere length. Cell Rep. 19:2529–2543. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Menin C, Bojnik E, Del Bianco P, Elefanti L, Gianesin K, Keppel S, Stagni C, Mocellin S, Vecchiato A and De Rossi A: Differences in telomere length between sporadic and familial cutaneous melanoma. Br J Dermatol. 175:937–943. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kammori M, Takubo K, Nakamura K, Furugouri E, Endo H, Kanauchi H, Mimura Y and Kaminishi M: Telomerase activity and telomere length in benign and malignant human thyroid tissues. Cancer Lett. 159:175–181. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Matthews P, Jones CJ, Skinner J, Haughton M, de Micco C and Wynford-Thomas D: Telomerase activity and telomere length in thyroid neoplasia: Biological and clinical implications. J Pathol. 194:183–193. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Dong C and Hemminki K: Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer. 92:144–150. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Jendrzejewski J, Tomsic J, Lozanski G, Labanowska J, He H, Liyanarachchi S, Nagy R, Ringel MD, Kloos RT, Heerema NA and de la Chapelle A: Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 96:1876–1880. 2011. View Article : Google Scholar | |
|
Capezzone M, Cantara S, Marchisotta S, Filetti S, De Santi MM, Rossi B, Ronga G, Durante C and Pacini F: Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab. 93:3950–3957. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Capezzone M, Cantara S, Marchisotta S, Busonero G, Formichi C, Benigni M, Capuano S, Toti P, Pazaitou-Panayiotou K, Caruso G, et al: Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer. J Clin Endocrinol Metab. 96:1852–1856. 2011. View Article : Google Scholar | |
|
He M, Bian B, Gesuwan K, Gulati N, Zhang L, Nilubol N and Kebebew E: Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer. Thyroid. 23:301–307. 2013. View Article : Google Scholar : | |
|
Gramatges MM, Morton LM, Yasui Y, Arnold MA, Neglia JP, Leisenring WM, Machiela MJ, Dagnall CL, Chanock SJ, Armstrong GT, et al: Telomere length-associated genetic variants and the risk of thyroid cancer in survivors of childhood cancer: A report from the childhood cancer survivor study (CCSS). Cancer Epidemiol Biomarkers Prev. 28:417–419. 2019. View Article : Google Scholar : | |
|
Li J, An C, Zheng H, Lei T, Zhang N, Zheng Y and Yang M: Leukocyte telomere length and risk of papillary thyroid carcinoma. J Clin Endocrinol Metab. 104:2712–2718. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Graham MK and Meeker A: Telomeres and telomerase in prostate cancer development and therapy. Nat Rev Urol. 14:607–619. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Chang WS, Tsai CW, Bau DT, Xu Y, Davis JW, Thompson TC, Logothetis CJ and Gu J: Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients. EBioMedicine. 52:1026162020. View Article : Google Scholar : PubMed/NCBI | |
|
Tsai CW, Chang WS, Xu J, Xu Y, Huang M, Pettaway C, Bau DT and Gu J: Leukocyte telomere length is associated with aggressive prostate cancer in localized African American prostate cancer patients. Carcinogenesis. 41:1213–1218. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hu R, Hua XG and Jiang QC: Associations of telomere length in risk and recurrence of prostate cancer: A meta-analysis. Andrologia. 51:e133042019. View Article : Google Scholar : PubMed/NCBI | |
|
Luxton JJ, McKenna MJ, Lewis AM, Taylor LE, Jhavar SG, Swanson GP and Bailey SM: Telomere length dynamics and chromosomal instability for predicting individual radiosensitivity and risk via machine learning. J Pers Med. 11:1882021. View Article : Google Scholar : PubMed/NCBI | |
|
Gu CY, Jin SM, Qin XJ, Zhu Y, Bo D, Lin GW, Shi GH and Ye DW: Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk. J Cancer. 10:6170–6174. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA and Meeker AK: Telomere length as a risk factor for hereditary prostate cancer. Prostate. 74:359–364. 2014. View Article : Google Scholar | |
|
Julin B, Shui I, Heaphy CM, Joshu CE, Meeker AK, Giovannucci E, De Vivo I and Platz EA: Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer. Br J Cancer. 112:769–776. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Renner W, Krenn-Pilko S, Gruber HJ, Herrmann M and Langsenlehner T: Relative telomere length and prostate cancer mortality. Prostate Cancer Prostatic Dis. 21:579–583. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Svenson U, Roos G and Wikström P: Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival. Tumour Biol. 39:10104283176922362017. View Article : Google Scholar : PubMed/NCBI | |
|
Wulaningsih W, Astuti Y, Matsuguchi T, Anggrandariyanny P and Watkins J; PILAR Research Network: Circulating Prostate-specific antigen and telomere length in a nationally representative sample of men without history of prostate cancer. Prostate. 77:22–32. 2017. View Article : Google Scholar | |
|
Heaphy CM, Haffner MC, Graham MK, Lim D, Davis C, Corey E, Epstein JI, Eisenberger MA, Wang H, De Marzo AM, et al: Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate. Hum Pathol. 101:70–79. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, De Vivo I, Hayes RB and Savage SA: The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell. 8:405–413. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Joshu CE, Peskoe SB, Heaphy CM, Kenfield SA, Mucci LA, Giovannucci EL, Stampfer MJ, Yoon G, Lee TK, Hicks JL, et al: Current or recent smoking is associated with more variable telomere length in prostate stromal cells and prostate cancer cells. Prostate. 78:233–238. 2018. View Article : Google Scholar : | |
|
Heaphy CM, Joshu CE, Barber JR, Davis C, Zarinshenas R, De Marzo AM, Lotan TL, Sfanos KS, Meeker AK, Platz EA, et al: Racial difference in prostate cancer cell telomere lengths in men with higher grade prostate cancer: A clue to the racial disparity in prostate cancer outcomes. Cancer Epidemiol Biomarkers Prev. 29:676–680. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Luu HN, Long J, Wen W, Zheng Y, Cai Q, Gao YT, Zheng W and Shu XO: Association between genetic risk score for telomere length and risk of breast cancer. Cancer Causes Control. 27:1219–1228. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kroupa M, Rachakonda S, Vymetalkova V, Tomasova K, Liska V, Vodenkova S, Cumova A, Rossnerova A, Vodickova L, Hemminki K, et al: Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients. Mutagenesis. 35:491–497. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Samavat H, Xun X, Jin A, Wang R, Koh WP and Yuan JM: Association between prediagnostic leukocyte telomere length and breast cancer risk: The Singapore Chinese Health Study. Breast Cancer Res. 21:502019. View Article : Google Scholar : PubMed/NCBI | |
|
Pellatt AJ, Wolff RK, Torres-Mejia G, John EM, Herrick JS, Lundgreen A, Baumgartner KB, Giuliano AR, Hines LM, Fejerman L, et al: Telomere length, telomere-related genes, and breast cancer risk: The breast cancer health disparities study. Genes Chromosomes Cancer. 52:595–609. 2013.PubMed/NCBI | |
|
Wang Z, Zhang Z, Guo Y, Shui H, Liu G, Jin T and Wang H: Shorter telomere length is associated with increased breast cancer risk in a Chinese Han population: A Case-Control analysis. J Breast Cancer. 21:391–398. 2018. View Article : Google Scholar | |
|
Shen J, Terry MB, Gurvich I, Liao Y, Senie RT and Santella RM: Short telomere length and breast cancer risk: A study in sister sets. Cancer Res. 67:5538–5544. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pavanello S, Varesco L, Gismondi V, Bruzzi P and Bolognesi C: Leucocytes telomere length and breast cancer risk/susceptibility: A case-control study. PLoS One. 13:e01975222018. View Article : Google Scholar | |
|
Duggan C, Risques R, Alfano C, Prunkard D, Imayama I, Holte S, Baumgartner K, Baumgartner R, Bernstein L, Ballard-Barbash R, et al: Change in peripheral blood leukocyte telomere length and mortality in breast cancer survivors. J Natl Cancer Inst. 106:dju0352014. View Article : Google Scholar : PubMed/NCBI | |
|
Ceja-Rangel HA, Sánchez-Suárez P, Castellanos-Juárez E, Peñaroja-Flores R, Arenas-Aranda DJ, Gariglio P and Benítez-Bribiesca L: Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines. Tumour Biol. 37:11917–11926. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kammori M, Sugishita Y, Okamoto T, Kobayashi M, Yamazaki K, Yamada E and Yamada T: Telomere shortening in breast cancer correlates with the pathological features of tumor progression. Oncol Rep. 34:627–632. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Barczak W, Rozwadowska N, Romaniuk A, Lipińska N, Lisiak N, Grodecka-Gazdecka S, Książek K and Rubiś B: Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer. Oncol Lett. 11:2305–2309. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Eyüboğlu İP, Yenmiş G, Bingöl EN, Yüksel Ş, Tokat F, Özbek P, Güllü Amuran G, Yakıcıer C and Akkiprik M: Next-generation sequencing identifies BRCA1 and/or BRCA2 mutations in Women at high hereditary risk for breast cancer with shorter telomere length. OMICS. 24:5–15. 2020. View Article : Google Scholar | |
|
Badie S, Escandell JM, Bouwman P, Carlos AR, Thanasoula M, Gallardo MM, Suram A, Jaco I, Benitez J, Herbig U, et al: BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping. Nat Struct Mol Biol. 17:1461–1469. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Thorvaldsdottir B, Aradottir M, Stefansson OA, Bodvarsdottir SK and Eyfjörd JE: Telomere length is predictive of breast cancer risk in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 26:1248–1254. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ennour-Idrissi K, Maunsell E and Diorio C: Telomere length and breast cancer prognosis: A systematic review. Cancer Epidemiol Biomarkers Prev. 26:3–10. 2017. View Article : Google Scholar | |
|
Garland SN, Johnson B, Palmer C, Speck RM, Donelson M, Xie SX, DeMichele A and Mao JJ: Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res. 16:4132014. View Article : Google Scholar : PubMed/NCBI | |
|
Alhareeri AA, Archer KJ, Fu H, Lyon DE, Elswick RK Jr, Kelly DL, Starkweather AR, Elmore LW, Bokhari YA and Jackson-Cook CK: Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: A longitudinal study. Breast Cancer Res. 22:1372020. View Article : Google Scholar : PubMed/NCBI | |
|
Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Pepłońska B, Sherman ME and Savage SA: Leukocyte telomere length in a population-based case-control study of ovarian cancer: A pilot study. Cancer Causes Control. 21:77–82. 2010. View Article : Google Scholar | |
|
Kuhn E, Meeker AK, Visvanathan K, Gross AL, Wang TL, Kurman RJ and Shih IeM: Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma. Mod Pathol. 24:1139–1145. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Vajpeyi R: WHO Classification of Tumours: Pathology and genetics of tumours of the breast and female genital organs. J Clin Pathol. 58:671–672. 2005. | |
|
Martinez-Delgado B, Anowsky K, Inglada-Perez L, de la Hoya M, Caldes T, Vega A, Blanco A, Martin T, Gonzalez-Sarmiento R, Blasco M, et al: Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases. J Med Genet. 49:341–344. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Falandry C, Horard B, Bruyas A, Legouffe E, Cretin J, Meunier J, Alexandre J, Delecroix V, Fabbro M, Certain MN, et al: Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: A multicenter GINECO study. Aging (Albany NY). 7:1066–1076. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yang M, Prescott J, Poole EM, Rice MS, Kubzansky LD, Idahl A, Lundin E, De Vivo I and Tworoger SS: Prediagnosis leukocyte telomere length and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 26:339–345. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, et al: Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 45:371–384. 384e1–2. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Terry KL, Tworoger SS, Vitonis AF, Wong J, Titus-Ernstoff L, De Vivo I and Cramer DW: Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 21:504–512. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kotsopoulos J, Prescott J, De Vivo I, Fan I, Mclaughlin J, Rosen B, Risch H, Sun P and Narod SA: Telomere length and mortality following a diagnosis of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 23:2603–2606. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Antoun S, Atallah D, Tahtouh R, Assaf MD, Moubarak M, Ayoub EN, Chahine G and Hilal G: Glucose restriction combined with chemotherapy decreases telomere length and cancer antigen-125 secretion in ovarian carcinoma. Oncol Lett. 19:1338–1350. 2020.PubMed/NCBI | |
|
Victorelli S and Passos JF: Telomeres and cell senescence-size matters not. EBioMedicine. 21:14–20. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kim B, Ryu KJ, Lee S and Kim T: Changes in telomere length and senescence markers during human ovarian tissue cryopreservation. Sci Rep. 11:22382021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang DK, Ngan HY, Cheng RY, Cheung AN, Liu SS and Tsao SW: Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer. Eur J Cancer. 35:154–160. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Maida Y, Kyo S, Forsyth NR, Takakura M, Sakaguchi J, Mizumoto Y, Hashimoto M, Nakamura M, Nakao S and Inoue M: Distinct telomere length regulation in premalignant cervical and endometrial lesions: Implications for the roles of telomeres in uterine carcinogenesis. J Pathol. 210:214–223. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Wei S, Ma H, Jin G, Hu Z, Suping H, Li D, Hang D, Wu X and Li N: Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women. Cancer Me. 8:4845–4851. 2019. View Article : Google Scholar | |
|
Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E and Lingner J: Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science. 318:798–801. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Deng Z, Wang Z, Xiang C, Molczan A, Baubet V, Conejo-Garcia J, Xu X, Lieberman PM and Dahmane N: Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci. 125:4383–4394. 2012.PubMed/NCBI | |
|
Oh BK, Keo P, Bae J, Ko JH and Choi JS: Variable TERRA abundance and stability in cervical cancer cells. Int J Mol Med. 39:1597–1604. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Déjardin J and Kingston RE: Purification of proteins associated with specific genomic Loci. Cell. 136:175–186. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kappei D, Butter F, Benda C, Scheibe M, Draškovič I, Stevense M, Novo CL, Basquin C, Araki M, Krastev DB, et al: HOT1 is a mammalian direct telomere repeat-binding protein contributing to telomerase recruitment. EMBO J. 32:1681–1701. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou S, Xiao Y, Zhuang Y, Liu Y, Zhao H, Yang H, Xie C, Zhou F and Zhou Y: Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening. Oncol Rep. 38:515–521. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Du J, Xue W, Ji Y, Zhu X, Gu Y, Zhu M, Wang C, Gao Y, Dai J, Ma H, et al: U-shaped association between telomere length and esophageal squamous cell carcinoma risk: A case-control study in Chinese population. Front Med. 9:478–486. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, Gu J and Wu X: Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila). 2:459–465. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng YL, Hu N, Sun Q, Wang C and Taylor PR: Telomere attrition in cancer cells and telomere length in tumor stroma cells predict chromosome instability in esophagealsquamous cell carcinoma: A genome-wide analysis. Cancer Res. 69:1604–1614. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Lin SW, Abnet CC, Freedman ND, Murphy G, Risques R, Prunkard D, Rabinovitch P, Pan QJ, Roth MJ, Wang GQ, et al: Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma. BMC Cancer. 13:5782013. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Song Y, Xu Y, Shen Y, Zhang N, Yang M and Yu D: Identification of Leukocyte telomere length-related genetic variants contributing to predisposition of Esophageal Squamous Cell Carcinoma. J Cancer. 11:5025–5031. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Yan C, Du J, Ji Y, Gao Y, Zhu X, Yu F, Huang T, Dai J, Ma H, et al: Genetic variants affecting telomere length are associated with the prognosis of esophageal squamous cell carcinoma in a Chinese population. Mol Carcinog. 56:1021–1029. 2017. View Article : Google Scholar | |
|
Shi J, Sun F, Peng L, Li B, Liu L, Zhou C, Han J, Zhang L, Zhou L, Zhang X, et al: Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinoma. Int J Cancer. 132:2799–2807. 2013. View Article : Google Scholar | |
|
Hao XD, Yang Y, Song X, Zhao XK, Wang LD, He JD, Kong QP, Tang NL and Zhang YP: Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer. Oncol Rep. 29:226–236. 2013. View Article : Google Scholar | |
|
Yu Q, Yang J, Liu B, Li W, Hu G, Qiu H, Huang L, Xiong H and Yuan X: Combined effects of leukocyte telomere length, p53 polymorphism and human papillomavirus infection on esophageal squamous cell carcinoma in a Han Chinese population. Cancer Epidemiol. 38:569–575. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wennerström EC, Risques RA, Prunkard D, Giffen C, Corley DA, Murray LJ, Whiteman DC, Wu AH, Bernstein L, Ye W, et al: Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Med. 5:2657–2665. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Pan W, Du J, Shi M, Jin G and Yang M: Short leukocyte telomere length, alone and in combination with smoking, contributes to increased risk of gastric cancer or esophageal squamous cell carcinoma. Carcinogenesis. 38:12–18. 2017. View Article : Google Scholar | |
|
Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Yamada H, Yoshida D, Ohmori T, Maeda K, et al: Telomere length in leukocyte DNA in gastric cancer patients and its association with Clinicopathological features and prognosis. Anticancer Res. 37:1997–2001. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hou L, Savage SA, Blaser MJ, Perez-Perez G, Hoxha M, Dioni L, Pegoraro V, Dong LM, Zatonski W, Lissowska J, et al: Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 18:3103–3109. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Qu F, Li R, He X, Li Q, Xie S, Gong L, Ji G, Lu J and Bao G: Short telomere length in peripheral blood leukocytes predicts poor prognosis and indicates an immunosuppressive phenotypegastric cancer patients. Mol Oncol. 9:727–739. 2015. View Article : Google Scholar | |
|
Wang Z, Koh WP, Jin A, Wang R and Yuan JM: Telomere length and risk of developing gastric adenocarcinoma: The Singapore Chinese Health Study. Gastric Cancer. 2:598–605. 2018. View Article : Google Scholar | |
|
Weischer M, Nordestgaard BG, Cawthon RM, Freiberg JJ, Tybjærg-Hansen A and Bojesen SE: Short telomere length, cancer survival, and cancer risk in 47102 individuals. J Natl Cancer Inst. 105:459–468. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Bao G, Huo T, Wang Z, He X and Dong G: Constitutive telomere length and gastric cancer risk: Case-control analysis in Chinese Han population. Cancer Sci. 100:1300–1305. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Lei T, Zhang N, Zheng Y, Kou P, Shang S and Yang M: Leukocyte telomere length and risk of gastric cardia adenocarcinoma. Sci Rep. 8:145842018. View Article : Google Scholar : PubMed/NCBI | |
|
Tahara T, Shibata T, Kawamura T, Horiguchi N, Okubo M, Nakano N, Ishizuka T, Nagasaka M, Nakagawa Y and Ohmiya N: Telomere length shortening in gastric mucosa is a field effect associated with increased risk of gastric cancer. Virchows Arch. 469:19–24. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Heo YR and Lee JH: Association between telomere length and PIK3CA amplification in gastric cancer. Clin Exp Med. 18:133–134. 2018. View Article : Google Scholar | |
|
Lili M, Yuxiang F, Zhongcheng H, Ying S, Ru C, Rong X and Jiang L: Genetic variations associated with telomere length affect the risk of gastric carcinoma. Medicine (Baltimore). 99:e205512020. View Article : Google Scholar : PubMed/NCBI | |
|
Du J, Zhu X, Xie C, Dai N, Gu Y, Zhu M, Wang C, Gao Y, Pan F, Ren C, et al: Telomere length, genetic variants and gastric cancer risk in a Chinese population. Carcinogenesis. 36:963–970. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Choi BJ, Yoon JH, Kim O, Choi WS, Nam SW, Lee JY and Park WS: Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer. World J Gastroenterol. 21:9328–9336. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, et al: Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study. Int J Cancer. 144:1275–1283. 2019. View Article : Google Scholar | |
|
Duell EJ: Telomere length and pancreatic cancer risk: Breaking down the evidence. Gut. 66:12017. View Article : Google Scholar | |
|
Luu HN, Huang JY, Wang R, Adams-Haduch J, Jin A, Koh WP and Yuan JM: Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from a prospective study. PLoS One. 14:e02216972019. View Article : Google Scholar : PubMed/NCBI | |
|
Campa D, Mergarten B, De Vivo I, Boutron-Ruault MC, Racine A, Severi G, Nieters A, Katzke VA, Trichopoulou A, Yiannakouris N, et al: Leukocyte telomere length in relation to pancreatic cancer risk: A prospective study. Cancer Epidemiol Biomarkers Prev. 23:2447–2454. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Mormile R: Telomere length and pancreatic cancer risk-letter. Cancer Epidemiol Biomarkers Prev. 26:11572017. View Article : Google Scholar : PubMed/NCBI | |
|
Skinner HG, Gangnon RE, Litzelman K, Johnson RA, Chari ST, Petersen GM and Boardman LA: Telomere length and pancreatic cancer: A case-control study. Cancer Epidemiol Biomarkers Prev. 21:2095–2100. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang R, Zhao J, Xu J and Liu F: Association of peripheral leukocyte telomere length and its variation with pancreatic cancer and colorectal cancer risk in Chinese population. Oncotarget. 7:38579–38585. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Antwi SO, Bamlet WR, Broderick BT, Chaffee KG, Oberg A, Jatoi A, Boardman LA and Petersen GM: Genetically predicted telomere length is not associated with pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 26:971–974. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Antwi SO, Bamlet WR, Rabe KG, Cawthon RM, Umudi I, Druliner BR, Sicotte H, Oberg AL, Jatoi A, Boardman LA and Petersen GM: Leukocyte telomere length and its interaction with germline variation in Telomere-Related genes in relation to pancreatic adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 29:1492–1500. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hamada T, Yuan C, Bao Y, Zhang M, Khalaf N, Babic A, Morales-Oyarvide V, Cochrane BB, Gaziano JM, Giovannucci EL, et al: Prediagnostic leukocyte telomere length and pancreatic cancer survival. Cancer Epidemiol Biomarkers Prev. 28:1868–1875. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bao Y, Prescott J, Yuan C, Zhang M, Kraft P, Babic A, Morales-Oyarvide V, Qian ZR, Buring JE, Cochrane BB, et al: Leucocyte telomere length genetic variants at the TERT gene region and risk of pancreatic cancer. Gut. 66:1116–1122. 2017. View Article : Google Scholar | |
|
Posch A, Hofer-Zeni S, Klieser E, Primavesi F, Naderlinger E, Brandstetter A, Filipits M, Urbas R, Swiercynski S, Jäger T, et al: Hot Spot TERT promoter mutations are rare in sporadic pancreatic neuroendocrine Neoplasms and associated with telomere length and epigenetic expression patterns. Cancers (Basel). 12:16252020. View Article : Google Scholar : PubMed/NCBI | |
|
Mormile R: Leukocyte telomere length and pancreatic cancer survival: A consequence of activation of IL-6 signaling pathway in the carcinogenic process? J Gastrointest Cancer. 51:720–721. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kroupa M, Rachakonda SK, Liska V, Srinivas N, Urbanova M, Jiraskova K, Schneiderova M, Vycital O, Vymetalkova V, Vodickova L, et al: Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis. Br J Cance. 121:344–350. 2019. View Article : Google Scholar | |
|
Lopez-Doriga A, Valle L, Alonso MH, Aussó S, Closa A, Sanjuan X, Barquero D, Rodríguez-Moranta F, Sanz-Pamplona R and Moreno V: Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response. Biochim Biophys Acta Mol Basis Dis. 1864:2992–3000. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Piñol-Felis C, Fernández-Marcelo T, Viñas-Salas J and Valls-Bautista C: Telomeres and telomerase in the clinical management of colorectal cancer. Clin Transl Oncol. 19:399–408. 2017. View Article : Google Scholar | |
|
Balc'h EL, Grandin N, Demattei MV, Guyétant S, Tallet A, Pagès JC, Ouaissi M, Lecomte and Charbonneau M: Measurement of telomere length in colorectal cancers for improved molecular diagnosis. Int J Mol Sci. 18:18712017. View Article : Google Scholar : PubMed/NCBI | |
|
Luu HN, Qi M, Wang R, Adams-Haduch J, Miljkovic I, Opresko PL, Jin A, Koh WP and Yuan JM: Association between leukocyte telomere length and colorectal cancer risk in the Singapore Chinese Health Study. Clin Transl Gastroenterol. 10:1–9. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Peacock SD, Massey TE, Vanner SJ and King WD: Telomere length in the colon is related to colorectal adenoma prevalence. PLoS One. 13:e02056972018. View Article : Google Scholar : PubMed/NCBI | |
|
Naing C, Aung K, Lai PK and Mak JW: Association between telomere length and the risk of colorectal cancer: A meta-analysis of observational studies. BMC Cancer. 17:242017. View Article : Google Scholar : PubMed/NCBI | |
|
Aljarbou F, Almobarak A, Binrayes A and Alamri HM: The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients. PLoS One. 13:e01971542018. View Article : Google Scholar : PubMed/NCBI | |
|
Park WJ, Bae SU, Heo YR, Jung SJ and Lee JH: Telomere shortening in non-tumorous and tumor mucosa is independently related to colorectal carcinogenesis in precancerous lesions. Int J Mol Epidemiol Genet. 8:53–58. 2017.PubMed/NCBI | |
|
Li J, Chang J, Tian J, Ke J, Zhu Y, Yang Y, Gong Y, Zou D, Peng X, Yang N, et al: A Rare Variant P507L in TPP1 interrupts TPP1-TIN2 interaction, influences telomere length, and confers colorectal cancer risk in Chinese population. Cancer Epidemiol Biomarkers Prev. 27:1029–1035. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ridout KK, Ridout SJ, Price LH, Sen S and Tyrka AR: Depression and telomere length: A meta-analysis. J Affect Disord. 191:237–247. 2016. View Article : Google Scholar : | |
|
AlAhwal MS, Zaben FA, Sehlo MG, Khalifa DA, Al-Aama JY, Edris S, Ashy JA and Koenig HG: Depression and telomere length in colorectal cancer patients in Saudi Arabia. Asian J Psychiatr. 40:130–131. 2019. View Article : Google Scholar | |
|
Ko E, Seo HW and Jung G: Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma. Hepatology. 67:1378–1391. 2018. View Article : Google Scholar | |
|
Ma LJ, Wang XY, Duan M, Liu LZ, Shi JY, Dong LQ, Yang LX, Wang ZC, Ding ZB and Ke AW: Telomere length variation in tumor cells and cancer-associated fibroblasts: Potential biomarker for hepatocellular carcinoma. J Pathol. 243:407–417. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HW, Park TI, Jang SY, Park SY, Park WJ, Jung SJ and Lee JH: Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma. Medicine (Baltimore). 96:e57662017. View Article : Google Scholar : PubMed/NCBI | |
|
Ningarhari M, Caruso S, Hirsch TZ, Bayard Q, Franconi A, Védie AL, Noblet B, Blanc JF, Amaddeo G, Ganne N, et al: Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target. J Hepatol. 74:1155–1166. 2021. View Article : Google Scholar | |
|
Zeng H, Wu HC, Wang Q, Yang HI, Chen CJ, Santella RM and Shen J: Telomere length and risk of hepatocellular carcinoma: A nested Case-control study in Taiwan cancer screening program cohort. Anticancer Res. 37:637–644. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cheng Y, Yu C, Huang M, Du F, Song C, Ma Z, Zhai X, Yang Y, Liu J, Bei JX, et al: Genetic association of telomere length with hepatocellular carcinoma risk: A Mendelian randomization analysis. Cancer Epidemiol. 50:39–45. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Feng W, Yu D, Li B, Luo OY, Xu T, Cao Y and Ding Y: Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence. Biosci Rep. 37:BSR201606212017. View Article : Google Scholar : PubMed/NCBI | |
|
Nikolouzakis TK, Stivaktakis PD, Apalaki P, Kalliantasi K, Sapsakos TM, Spandidos DA, Tsatsakis A, Souglakos J and Tsiaoussis J: Effect of systemic treatment on the micronuclei frequency in the peripheral blood of patients with metastatic colorectal cancer. Oncol Lett. 17:2703–2712. 2019.PubMed/NCBI | |
|
Nikolouzakis TK, Vakonaki E, Stivaktakis PD, Alegakis A, Berdiaki A, Razos N, Souglakos J, Tsatsakis A and Tsiaoussis J: Novel prognostic biomarkers in metastatic and locally advanced colorectal cancer: Micronuclei frequency and telomerase activity in peripheral blood lymphocytes. Front Oncol. 11:6836052021. View Article : Google Scholar : PubMed/NCBI | |
|
Guterres AN and Villanueva J: Targeting telomerase for cancer therapy. Oncogene. 39:5811–5824. 2020. View Article : Google Scholar : PubMed/NCBI |
